Cantor Fitzgerald Initiates SPRO with Overweight and $6 Target
Cantor Fitzgerald started SPRO with an Overweight rating and a $6 price target, spotlighting meaningful upside for a stock trading near $1.14. While the piece also notes numerous other analysts initiating coverage on different biotechs, SPRO is the focal point for potential re-rating. If the target proves credible and coverage expands, SPRO could attract momentum buyers and improve near-term liquidity.
View signal analysis